Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Orexigen Therapeutics, Inc. | 69,600 | reported | 13 Oct 2017 | tx 10+1,058,804 |
| BillionToOne, Inc. | 10,000 | reported | 07 Nov 2025 | tx 11+145,100−145,000 |
| Nuwellis, Inc. | 7,000 | reported | 22 Jan 2021 | tx 1+7,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Nov 2025 | PURCHASE | BillionToOne, Inc. | 100 | 60.00 USD | |
| 07 Nov 2025 | OTHER | BillionToOne, Inc. | 600 | — | |
| 07 Nov 2025 | OTHER | BillionToOne, Inc. | 600 | — | |
| 07 Nov 2025 | OTHER | BillionToOne, Inc. | 15,000 | — | deriv |
| 07 Nov 2025 | OTHER | BillionToOne, Inc. | 79,400 | — | deriv |
| 07 Nov 2025 | OTHER | BillionToOne, Inc. | 79,400 | — | deriv |
| 07 Nov 2025 | OTHER | BillionToOne, Inc. | 10,000 | — | deriv |
| 07 Nov 2025 | OTHER | BillionToOne, Inc. | 15,000 | — | deriv |
| 07 Nov 2025 | OTHER | BillionToOne, Inc. | 40,000 | — | deriv |
| 07 Nov 2025 | OTHER | BillionToOne, Inc. | 40,000 | — | deriv |
| 07 Nov 2025 | OTHER | BillionToOne, Inc. | 10,000 | — | deriv |
| 22 Jan 2021 | GRANT_AWARD | Nuwellis, Inc. | 7,000 | 0.00 USD | deriv |
| 13 Oct 2017 | GRANT_AWARD | Orexigen Therapeutics, Inc. | 69,600 | 0.00 USD | deriv |
| 31 May 2017 | GRANT_AWARD | Orexigen Therapeutics, Inc. | 1,704 | 1.55 USD | |
| 03 Feb 2017 | GRANT_AWARD | Orexigen Therapeutics, Inc. | 87,000 | — | deriv |
| 03 Feb 2017 | GRANT_AWARD | Orexigen Therapeutics, Inc. | 43,500 | — | deriv |
| 12 Jul 2016 | GRANT_AWARD | Orexigen Therapeutics, Inc. | 78,750 | — | deriv |
| 12 Jul 2016 | GRANT_AWARD | Orexigen Therapeutics, Inc. | 26,250 | — | deriv |
| 12 Jul 2016 | GRANT_AWARD | Orexigen Therapeutics, Inc. | 131,250 | — | deriv |
| 12 Jul 2016 | GRANT_AWARD | Orexigen Therapeutics, Inc. | 15,750 | — | deriv |
| 02 Feb 2016 | GRANT_AWARD | Orexigen Therapeutics, Inc. | 255,000 | 0.00 USD | deriv |
| 01 Dec 2015 | GRANT_AWARD | Orexigen Therapeutics, Inc. | 350,000 | — | deriv |